双侧全膝关节置换术的大麻二酚
大麻二酚 (CBD) 口服液对接受双侧全膝关节置换术患者的影响:随机、对照、平行、三盲、试点研究
研究概览
研究类型
注册 (实际的)
阶段
- 第四阶段
联系人和位置
学习地点
-
-
New York
-
New York、New York、美国、10021
- Hospital for Special Surgery
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
描述
纳入标准:
- 18 至 70 岁
- 计划与参与的外科医生在同一天进行双侧全膝关节置换术
- 美国麻醉师协会 (ASA) 身体状况 1 或 2
排除标准:
- ASA 3 及以上
- 重量 < 40kg
- 计划使用全身麻醉
- 研究方案主要组成部分的禁忌症
- 过去 3 个月内使用大麻或大麻素(娱乐和/或医疗)
- 在过去 30 天内以任何形式使用或摄入大麻籽或大麻油
- 长期使用阿片类药物(>3 个月)
- 香豆素用途
- 当前使用的 SSRI 或 SNRI
- 药物滥用或依赖史
- 患有重大精神疾病或病史
- 严重的心血管疾病
- 严重的肝或肾功能不全(转氨酶水平高于 ULN)
- 癫痫史
- 风湿性疾病、自身免疫性疾病或免疫缺陷(例如 类风湿性关节炎、银屑病关节炎、炎症性肠病、多发性硬化症等)
- 使用丙戊酸盐或氯巴占
- 已知或疑似对大麻素或研究药物中的任何赋形剂(即 芝麻油、三氯蔗糖、草莓味)
- 积极使用类固醇——入院时口服类固醇
- 压力剂量类固醇
- 非英语人士
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:欧拉甜顺丰
|
Ora-sweet SF 安慰剂
|
|
实验性的:400毫克大麻二酚
|
Epidiolex(大麻二酚)口服液
其他名称:
|
|
实验性的:800毫克大麻二酚
|
Epidiolex(大麻二酚)口服液
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Cumulative Opioid Usage in First 72 Hours Postoperatively
大体时间:0-72 hours postoperatively
|
Cumulative opioid usage over the first 72 hours after surgery.
Measured in morphine equivalents (ME), a scale that measure opioid usage among all opioid medications
|
0-72 hours postoperatively
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
CBD的药代动力学
大体时间:给药后0、1、2、3、4、6小时
|
血液中 CBD 的水平。
这是使用抽血和实验室分析来测量的。
|
给药后0、1、2、3、4、6小时
|
|
简要疼痛量表简表
大体时间:术前;术后当天早上 (POD) 1、2、3、4、7 和 3 个月
|
Brief Pain inventory 简表衡量疼痛的严重程度及其对功能的影响。
它从 0-10 衡量疼痛,0 表示完全没有疼痛,10 表示可以想象到的最严重的疼痛。
它从 0-10 衡量对功能的影响,0 表示没有任何影响,10 表示完全有影响。
|
术前;术后当天早上 (POD) 1、2、3、4、7 和 3 个月
|
|
Levels of Plasma Inflammatory Marker Interleukin-6
大体时间:Preoperative, Postoperative day 1
|
Interleukin-6 (IL6) is an inflammatory marker found in plasma. The levels of IL6 are measured using blood draws and lab analysis. The outcome measure below indicates the difference between IL6 levels on postoperative day 1 and preoperative. |
Preoperative, Postoperative day 1
|
|
NRS Pain at Rest
大体时间:Preoperatively; postoperatively in the PACU, morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
Pain at rest measured using numerical rating scale(NRS) from 0-10, with 0 being no pain at all to 10 being the worst pain imaginable.
|
Preoperatively; postoperatively in the PACU, morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
|
NRS Pain With Movement
大体时间:Preoperatively; morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
Pain with movement using numerical rating scale(NRS) from 0-10, with 0 being no pain at all to 10 being the worst pain imaginable.
|
Preoperatively; morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
|
Incidence of Adverse Events
大体时间:Postoperatively in the PACU; morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
Adverse events, including allergic reactions, pyrexia (fever), somnolence (excessive sleepiness), GI problems (upset stomach, diarrhea), dry mouth, escalation of post-operative opioid requirement
|
Postoperatively in the PACU; morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
|
Opioid Related Symptom Distress Scale (ORSDS)
大体时间:Morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
Opioid related Symptom Distress Scale (ORSDS) measures opioid related side effects.
There are 12 side effects with 3 subcategories (severity, frequency, bothersomeness) each with 5 different responses (scored 0-4 with higher scores indicating worse symptoms).
The ORSDS composite score was calculated by averaging the scores for each symptom.
|
Morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
|
Anxiety Levels
大体时间:Preoperatively; Morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
Hospital Anxiety and Depression Scale (HADS) asks 14 questions, 7 about anxiety and 7 about depression.
Responses are scored from 0-3.
Responses between the two categories are summed and scoring is as follows: 0-7 = normal, 8-10=borderlines abnormal, 11-21=abnormal
|
Preoperatively; Morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
|
Cumulative Inpatient Analgesic Use (Non-opioid)
大体时间:POD0 - POD3
|
Total non-opioid medication usage
|
POD0 - POD3
|
|
Number of Participants With Opioid and Non-opioid Medication Use
大体时间:POD0 - POD3
|
Opioid and non-opioid medication use by count (%)
|
POD0 - POD3
|
|
Opioid & Non-opioid Analgesic Consumption
大体时间:At hospital discharge to POD7
|
Total opioid (morphine milligram equivalents) & non-opioid medication usage
|
At hospital discharge to POD7
|
|
Number of Participants With Opioid and Non-opioid Medication Use
大体时间:POD0 to POD7 and 3 months
|
Opioid & non-opioid medication use by count (%)
|
POD0 to POD7 and 3 months
|
|
Hospital Length of Stay
大体时间:At hospital discharge
|
Length of stay measured in hours from end of surgery to hospital discharge
|
At hospital discharge
|
|
Blinding Assessment
大体时间:POD4
|
Patients are asked which treatment they think they received.
The correctness of their guesses is then measured using the bang-blinding index to see if patients were able to accurately guess which treatment they received.
It is measured on a scale of -1 to 1. Scores closer to 0 indicate better blinding, or patients not being able to guess their treatment.
The index (number) is calculated as a group-level summary statistic, computed from the distribution of guesses across all participants in a group.
|
POD4
|
|
Time to Reach Discharge Physical Therapy Goals
大体时间:At hospital discharge
|
Physical therapy goals for total knee replacement include walking 100 feet, going up and down 4 stairs, and independent transfer (meaning they can move from a lying to standing position independently).
Patients need to complete these goals before being discharged
|
At hospital discharge
|
|
Range of Motion
大体时间:preoperatively, 6 weeks postoperatively.
|
Range of motion, or extension and flexion of the knees, are measured preoperatively and at the patients' 6 week surgeon visit.
It is measured in degrees
|
preoperatively, 6 weeks postoperatively.
|
|
Actigraphy Sleep Efficiency
大体时间:POD0 - POD3
|
Sleep quality assessed by actigraphy using ActiGraph wGT3X-BT activity monitor.
Higher sleep efficiency indicates better sleep quality.
Sleep efficiency was calculated between the hours of 11pm and 6am each night.
|
POD0 - POD3
|
|
Actigraphy Sleep Time
大体时间:POD0 - POD3
|
Sleep quality assessed by actigraphy using ActiGraph wGT3X-BT activity monitor.
Higher sleep time indicates better sleep quality.
Total sleep time was calculated between the hours of 11pm and 6am each night.
|
POD0 - POD3
|
|
Sleep Quality
大体时间:preoperatively; morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
Sleep quality assessed by Leeds sleep evaluation questionnaire (LSEQ). Responses to 10 questions will be measured on a slider scale ranging from 0-100. Higher scores indicate better outcomes. Getting to Sleep domain scores were calculated by averaging the responses to Questions 1-3 regarding falling asleep. Quality of Sleep domain scores were calculated by averaging the responses to Questions 4-5 regarding quality of sleep. Awake Following Sleep domain scores were calculated by averaging the responses to Questions 6-7 regarding awakening from sleep. Behaviour Following Wakening domain scores were calculated by averaging the responses to Questions 8-10 regarding feeling, balance, and coordination upon awakening. |
preoperatively; morning of postoperative day (POD) 1,2,3,4,7 and at 3 months
|
合作者和调查者
调查人员
- 首席研究员:Alexandra Sideris, PhD、Hospital for Special Surgery, New York
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 2019-1688
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
- 树液
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.